Drug recall · January 4, 2023
Glycopyrrolate Tablets recall
Why: Failed impurities/degradation specifications: Out of specification for unknown impurities.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-363-15
- Lots / codes
Lot#: 43313, 43342, Exp 12/2023
- Quantity
- 1237 cartons
- Company
- Avkare LLC, Pulaski, TN
- Distribution
- USA Nationwide
- Initiated
- December 22, 2022 · Voluntary: Firm initiated
- Classified
- December 28, 2022
- Reported
- January 4, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glycopyrronium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.